• There is an unmet need for a continuous, long term 28 days),
    ambulatory, non invasive medical device for monitoring of heart
    arrhythmias, vitals, and chronic diseases (e g COPD, heart failure)
  • CardiacSense has a clinically proven technology to address these
    needs in a wristband form factor
  • For in hospital and ambulatory use
  • FDA and CE clearances for heart arrhythmias are expected by early
    2020
  • FDA and CE clearances for blood pressure monitoring are expected by
    late 2020
  • Commercial products will be available in late 2020

Why are we here?

CONTINUOUS, LONG TERM, AMBULATORY, and NON-INVASIVE
monitoring of life-critical functions at MEDICALLY CERTIFIED
SENSITIVITY AND SPECIFICITY LEVELS, in order to track:
cardiac-sense-gorsel4
Atrial fibrillation
HEART
CONDITIONS

Atrial Fibrillation
Bradycardia
Tachycardia
Cardiac Arrest
Heart Failure

cardiac-sense-gorsel5
VITAL
SIGNS

Blood Pressure
Core Temperature
Pulse Rate
Respiratory Rate
Oxygen Saturation

cardiac-sense-gorsel6
Motion Tracking
WELL-BEING
METRICS

Activity Tracking
Calories Burned
Galvanic Skin Response
Mental Stress
Sleep Analysis

Our value proposition

  • Patent-protected state-ofthe-art sensors and algorithms
  • Holter-level accuracy for detection of heart arrhythmias
  • Capnograph level accuracy for respiratory rate
  • Finger level accuracy over the wrist of SPO2
  • Non-inflating, continuous, absolute blood pressure measurement

Design

Premium Design
22cm X 22cm X 10cm
Portable Bag
Only 3.5 Kg
Affordable cost

Advantage

High Goss
Color touch screen
Easy and patented
Fiber connection
99 Surgeon Settings
Completely portable
Fiber Retraction
Synchronization

Medical Watch for long-term continuous monitoring

Continuous measurement 24/7

Uzun süreli ve sürekli kalp aritmi tespiti için
bilinen tek etkili çözüm

``Unleash the Spaghetti…” The new bed-side monitoring device
replacement, for hospitals

Unique Technological Attributes: Heart Arrhythmia Detection

Unique optics
improve signal-tonoise and power
consumption

UPG (Ultra Photoplethysmography) Sensor

Single-charge operating time is 4 days

The OPTO-electro-mechanical sensor eliminates artifacts.

FDA & CE protocol for AF detection clearance

1 st (Preliminary) Clinical Trial 2

FDA threshold:

Over 96% beat-to-beat sensitivity between
ECG and PPG across 24 patients

over 96% beat-to-beat sensitivity between
ECG and PPG across 24 patients

2.(Pivotal) Clinical Study

FDA threshold:

over 95% consistency between medical watch and cardiologist diagnostic of AF detection across 30 patients.

First of its kind

Continuous long-term absolute Blood Pressure Measurement

• First-of–its-kind and unique in the market, noninflating Opto-electro-mechanical sensor over the wrist for continuous long-term blood pressure monitoring
• Accurate as A-line and inflating cuff
• 1 in 4 men and 1 in 5 women are suffering from hypertension (World Health Organization)
• Hypertension is a major cause of premature death worldwide and less than 20% has it under control
• One of the global targets for noncommunicable diseases is to reduce the prevalence of hypertension by 25% by 2025 (baseline 2010)

Reduce hospitalizations and treatment cost

Continuous Respiratory Rate in Ambulatory Conditions

Respiratory Rate During Sleep Apnea

Respiratory Rate of Patients with A-Fib & COPD & Sleep Apnea

Aritmi hastaları için solunum hızını ölçen CardiacSense haricinde başka bir bileklik cihazı yoktur.
The first solution for ambulatory conditions

Continuous Oxygen Saturation (SpO2) Over the Wrist

There is no other wristband device for arrhythmia patients other than CardiacSense, which is measured during the day.

FDA requirements: Mean error < 3%

  • Unique multi-wavelength optical sensor
  • 1 out of 2 adults suffer from sleep disorders
  • HR, RR and SPO2 are major parameters for monitoring and detection of such disorders
  • SpO2 is the 2 nd most important parameter in COPD and HF deterioration detection and together with RR makes is required for high accuracy results
  • Ambulatory continuous monitoring allows every person to monitor his sleep at home
Continuous monitoring, avoiding strokes

Atrial Fibrillation (A-Fib) Detection

There is no wristband device other than CardiacSense, which measures respiratory rate for arrhythmia patients.
  • There is no current solution for ambulatory long-term continuous detection and alerting for A-fib episodes
  • 80% of severe strokes happens following A-fib
  • On wrist unique comfortable continuous monitoring device
  • Detects, alerts and reduces the risk of having stroke
The only device to detect cardiac arrest at home

Ambulatory Comfortable Cardiac Arrest Detection

  • 70% of death cases due to CA happens during early hours of the morning while sleeping
  • There is no current solution for long-term continuous ambulatory detection and alerting when happens or short time before it happens.
  • 1.25 Thousandth of the population dies every year due to CA
  • On wrist unique comfortable monitoring device which can connect with AED’s
  • Detects, alerts and save lives

Key Benefits of CardiacSense Device

cardiac-sense-gorsel27

CONSUMERS

  • Vital Signs Monitoring
  • Peace of Mind
  • Life Saving

cardiac-sense-gorsel28

HOSPITALS

  • Wireless Monitoring
  • All-in-one
  • Nurse Load Reduction
  • Patient Mobility

cardiac-sense-gorsel31

NURSING HOMES

  • Wireless Monitoring
  • Nurse Load Reduction
  • Location Tracking

cardiac-sense-gorsel32

INSURANCE COMPANIES

  • Cost Reduction
  • Stroke Case Reduction
  • Mortality Rates Reduction

cardiac-sense-gorsel29

MONITORING CENTERS

  • All-in-one
  • Comfortable
  • Real-time Data
  • Cost-effective

cardiac-sense-gorsel30

ASSISTED LIVING

  • Peace of Mind
  • Physical Activity
  • Wireless Monitoring

cardiac-sense-gorsel33

HMOs

  • Patient Monitoring
  • Cost Reduction
  • Early Detection

Patient Big Data & AI Analytics for early detection of critical events through digital health applications such as Google Fit and Apple HealthKit

CardiacSense Medical Watch Connectivity Ecosystem

CardiacSense Hastane Ortamında Medikal Bileklik

CardiacSense Medical Watch

Medical as a Big Data Watch as a Collection
Big Data Platform Collection Platform

Extensive and broad clinical trials with leading medical institutions

Vision and implementation

In two years, people will be continuously monitored by their CardiacSense “hospital-on-the-wrist” in their daily lives as well as at the hospital

• Thousands of lives will be saved, and many others will experience significant quality-of-life improvements
• Commercial sales are expected to launch in Q2, 2020
• CardiacSense is a key driver in materializing the above vision